tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Caroline Palomeque, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst Caroline Palomeque, carries an average stock price target met ratio of 50% that have a potential upside of 133.16% achieved within 782 days.
Caroline Palomeque’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DARE, Dare Bioscience at 04-Sep-2025.
Analyst best performing recommendations are on AVXL (ANAVEX LIFE SCIENCES CORP).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 30-Nov-2015
$24
$19.72 (460.75%)
$24
6 days ago
(06-Jan-2026)
6/19 (31.58%)
$19.99 (498.50%)
1278
Buy
Since 16-Mar-2020
$20
$15.72 (367.29%)
$20
1 months 15 days ago
(28-Nov-2025)
4/19 (21.05%)
$16.54 (478.03%)
155
Buy
Since 24-Sep-2021
$28
$23.72 (554.21%)
$35
2 years 11 months 3 days ago
(09-Feb-2023)
0/2 (0%)
$17.59 (168.97%)
Hold
Since 06-Dec-2022
$11
$6.72 (157.01%)
$16
3 years 1 months 6 days ago
(06-Dec-2022)
3/6 (50%)
$2.62 (31.26%)
64
Buy
Since 16-May-2018
$40
$35.72 (834.58%)
$7
3 years 6 months 20 days ago
(23-Jun-2022)
1/2 (50%)
$29.55 (282.78%)
904
Which stock is Caroline Palomeque is most bullish on?
What Year was the first public recommendation made by Caroline Palomeque?
